LONA · LeonaBio Inc
United States · RS rating 17 · As of 2026-10-14
| Price | 5.39 USD |
|---|---|
| 1-day change | -16.2% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 8 / 11 / 88 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 25 / 37 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +53.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +53.9% |
| Market cap (USD) | $81.0M |